Panagora Asset Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-9,248
Closed -$9K – 3048
2020
Q4
$9K Sell
9,248
-583
-6% -$441 ﹤0.01% 2322
2020
Q3
$7K Buy
+9,831
New +$6.87K ﹤0.01% 2396

Other funds holding CHAQ.WS

Panagora Asset Management's CHAQ.WS Position: Q1 2021 in Review

Panagora Asset Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q1 2021, closing a stake of 9,248 shares — an estimated $9K sold.

Panagora Asset Management first reported a position in CHAQ.WS in Q3 2020 and held it in 2 quarters. The position peaked at $9K in Q4 2020. 22 funds tracked by Wall St. Rank hold CHAQ.WS as of Q1 2021.

  • Panagora Asset Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q1 2021 after selling out during the quarter.
  • Panagora Asset Management sold 9,248 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q1 2021, an estimated $9K.
  • Panagora Asset Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q3 2020 and held it in 2 quarters.
  • Panagora Asset Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $9K in Q4 2020.
  • 22 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q1 2021.

Based on Panagora Asset Management's 13F filing for Q1 2021, filed 12 May 2021.